These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4579612)

  • 41. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Liver function in liver transplantations].
    Lima-Gonçalves E; Machado MC; Bevilacqua RG; Cunha JC; Kieffer J; da Cunha JE; Gonçalez Y; Bacchella T; Srougi M; de Araujo Filho JP
    Rev Hosp Clin Fac Med Sao Paulo; 1969; (4):225-38. PubMed ID: 4898750
    [No Abstract]   [Full Text] [Related]  

  • 43. [Characterization of rejection in orthotopic liver transplantation in the dog. III. Anatomo-pathological findings].
    Bacchella T; Machado MC; da Cunha JE; Behmer OA; Duarte MI
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(5):215-22. PubMed ID: 6398901
    [No Abstract]   [Full Text] [Related]  

  • 44. Pathology of orthotopic liver transplantation in pigs and dogs. Autopsy and biopsy studies.
    Collan Y; Sivula A; Lempinen M
    Ann Chir Gynaecol Fenn; 1973; 62(4):204-18. PubMed ID: 4587707
    [No Abstract]   [Full Text] [Related]  

  • 45. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute cholestasis in the rat.
    Garay EA; Piccaluga A; Perez V; Royer M; Listrani J
    Acta Hepatosplenol; 1969; 16(4):221-30. PubMed ID: 5805605
    [No Abstract]   [Full Text] [Related]  

  • 48. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
    Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the efficacy of immunosuppressive regimens on orthotopic heart allografts.
    Kondo Y; Grogan JB; Cockrell JV; Kuramochi T; Smith GV; Hardy JD
    J Thorac Cardiovasc Surg; 1974 Apr; 67(4):612-20. PubMed ID: 4594431
    [No Abstract]   [Full Text] [Related]  

  • 50. Biochemical and ultrastructural changes in dog and pig livers procured for transplantation.
    Olszewski W; Rowiński W; Olszewska K; Danielewicz-Kotowicz A; Borowicz JW
    Acta Med Pol; 1973; 14(2):153-60. PubMed ID: 4579611
    [No Abstract]   [Full Text] [Related]  

  • 51. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 53. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
    Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
    Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
    Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
    [No Abstract]   [Full Text] [Related]  

  • 55. Increased immunogenicity of canine liver cell allografts.
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Surgery; 1981 May; 89(5):641-3. PubMed ID: 7013133
    [No Abstract]   [Full Text] [Related]  

  • 56. Allogeneic testis transplantation in dogs. Effect of prednisolone on the rejection phenomenon.
    Rubio ME; Hoschoian JC; Andrada JA; Mancini RE
    Medicina (B Aires); 1975; 35(1):23-8. PubMed ID: 1128210
    [No Abstract]   [Full Text] [Related]  

  • 57. Causes of death in the early postoperative period in orthotopic liver transplantations in the dog.
    Sivula A; Lempinen M; Paloheimo M; Turunen MT
    Ann Chir Gynaecol Fenn; 1973; 62(4):199-203. PubMed ID: 4587706
    [No Abstract]   [Full Text] [Related]  

  • 58. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunopathology of liver allografts and xenografts in nonhuman primates.
    Donato MF; Arosio E; Berti E; Gatti S; Piazzini A; Colledan M; Rossi G; Fassati LR; Galmarini D; Gridelli B
    Transplant Proc; 1993 Feb; 25(1 Pt 2):850-5. PubMed ID: 8442246
    [No Abstract]   [Full Text] [Related]  

  • 60. Revisiting liver transplant immunology: from the concept of immune engagement to the dualistic pathway paradigm.
    Reding R; Davies HF
    Liver Transpl; 2004 Sep; 10(9):1081-6. PubMed ID: 15349996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.